Net Income/(Loss) per Common Share |
Net Income/(Loss) per Common Share Basic net income/(loss) per common share is computed by dividing net income/(loss) by the weighted average number of common shares outstanding during each period. Diluted net income/(loss) per common share is computed by dividing net income/(loss) by the weighted average number of common shares and common share equivalents outstanding (if dilutive) during each period. The number of common share equivalents, which includes options and both restricted and performance stock units, is computed using the treasury stock method. With regard to the performance stock units, we assume that the associated performance targets will be met at the target level of performance for purposes of calculating diluted net income/(loss) per common share until such time that it is probable that the performance target will not be met.
The reconciliations of the denominators used to calculate basic and diluted net income/(loss) per common share for the three and nine months ended December 31, 2021 and 2020, respectively, are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, 2021 |
|
Three Months Ended December 31, 2020 |
|
Nine Months Ended December 31, 2021 |
|
Nine Months Ended December 31, 2020 |
Basic net income/(loss) per common share |
|
|
|
|
|
|
|
Net income/(loss) |
$ |
11,270 |
|
|
$ |
6,175 |
|
|
$ |
11,407 |
|
|
$ |
1,928 |
|
Weighted-average common shares outstanding |
33,340,000 |
|
|
33,180,562 |
|
|
33,292,614 |
|
|
33,110,877 |
|
Basic net income/(loss) per common share |
$ |
0.34 |
|
|
$ |
0.19 |
|
|
$ |
0.34 |
|
|
$ |
0.06 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, 2021 |
|
Three Months Ended December 31, 2020 |
|
Nine Months Ended December 31, 2021 |
|
Nine Months Ended December 31, 2020 |
Diluted net income/(loss) per common share |
|
|
|
|
|
|
|
|
Net income/(loss) |
|
$ |
11,270 |
|
|
$ |
6,175 |
|
|
$ |
11,407 |
|
|
$ |
1,928 |
|
Weighted-average common shares outstanding |
|
33,340,000 |
|
|
33,180,562 |
|
|
33,292,614 |
|
|
33,110,877 |
|
Common share equivalents: |
|
|
|
|
|
|
|
|
Stock options |
|
271 |
|
|
2,733 |
|
|
1,660 |
|
|
21,155 |
|
Restricted and performance stock units |
|
317,833 |
|
|
236,278 |
|
|
187,690 |
|
|
102,325 |
|
Weighted average shares outstanding – dilutive (1)
|
|
33,658,104 |
|
|
33,419,573 |
|
|
33,481,964 |
|
|
33,234,357 |
|
Diluted net income/(loss) per common share |
|
$ |
0.33 |
|
|
$ |
0.18 |
|
|
$ |
0.34 |
|
|
$ |
0.06 |
|
(1) For the three and nine months ended December 31, 2021, 45,099 and 139,843 equity awards, respectively, were not included in the calculation of diluted net income/(loss) per common share, as they would have had an anti-dilutive effect. For the three and nine months ended December 31, 2020, 250,668 and 246,005 equity awards respectively, were not included in the calculation of diluted net income/(loss) per common share, as they would have had an anti-dilutive effect.
|